Latest Conference Articles

October 19th 2017, 5:57pm

World Congress on Melanoma

Maria T. Landi, M.D., Ph.D., principal investigator at the National Cancer Institute (NCI) and National Institutes of Health (NIH) discusses a recent study that identified genetic variations that may be linked with increased melanoma risk.

October 19th 2017, 5:05pm

World Congress on Melanoma

Intralesional therapies – those delivered directly to the tumor site – used in conjunction with checkpoint inhibitors have shown improvements to the treatment of people with melanoma, says Robert Andtbacka, M.D., in a presentation at the 2017 World Congress of Melanoma.

July 10th 2017, 9:22pm

Ovarian Cancer National Conference

Many patients with cancer don't hesitate when discussing side effects like fatigue, nausea and neuropathy with their health care provider; however, there is often silence when it boils down to the sexual side effects of their treatment.

July 10th 2017, 8:22pm

Ovarian Cancer National Conference

The treatment landscape of ovarian cancer continues to change with the recent approvals of new agents.

July 10th 2017, 6:18pm

Ovarian Cancer National Conference

Audra Moran, CEO & President of the Ovarian Cancer Research Fund Alliance discusses the Ovarian Cancer National Conference.

July 10th 2017, 6:10pm

Ovarian Cancer National Conference

David Gershenson, M.D., of MD Anderson Cancer Center, explains the difficulty of advancing treatment of rare ovarian cancers: malignant ovarian germ cell tumors, sex cord stromal tumors, and types of epithelial tumors such as ovarian clear cell carcinoma, ovarian low-grade serous carcinoma, and mucinous tumors.

July 9th 2017, 7:00pm

Ovarian Cancer National Conference

For women with ovarian cancer, the message is clear: participating in clinical trials, even early-phase ones, offers the best hope for better treatments, but efforts are urgently needed at every level to ensure that more of these research opportunities are available.

July 9th 2017, 6:44pm

Ovarian Cancer National Conference

Strategies from expert oncology dieticians can help patients to eat an appropriate diet and maintain a healthy weight during and after treatment for ovarian cancer.

July 9th 2017, 6:23pm

Ovarian Cancer National Conference

Sarah Sciortino, MSW, LSW, Oncology Psychosocial Support Services Program Coordinator at University of Chicago Hospital, discusses the unique concerns that younger patients with ovarian cancer can face.

July 9th 2017, 6:20pm

Ovarian Cancer National Conference

Mark Gibbons of Caregiver Action Network discusses the emotions caregivers to patients with ovarian cancer may have.

July 9th 2017, 2:43am

Ovarian Cancer National Conference

Opening the 20th Annual Ovarian Cancer National Conference in Chicago, John Moroney, M.D., underscored the challenges that remain in the early detection and treatment of ovarian cancer, but also the tremendous hope that resides in robust clinical trial research.

July 9th 2017, 1:02am

Ovarian Cancer National Conference

Nita Karnik Lee, MD, MPH, of The University of Chicago Medicine, discusses what patients with ovarian cancer should know about when entering survivorship.

July 9th 2017, 12:56am

Ovarian Cancer National Conference

Mark Gibbons, senior director of external programs with the nonprofit Caregiver Action Network, explains the importance of caregivers taking care of themselves while at the Ovarian Cancer National Conference.

July 8th 2017, 8:14pm

Ovarian Cancer National Conference

Jennifer Lane-Riefler, MCHES, CFm, Executive Director of Cancer Services of Grant County, discusses the financial assistance opportunities available for patients with ovarian cancer.

June 13th 2017, 12:18am

FORCE Conference

Angela Schmidt Fishbaugh talks about being diagnosed with breast cancer after a mastectomy, changing her from a previvor to survivor.

June 11th 2017, 6:44pm

FORCE Conference

The idea of interfering with DNA’s self-repair capabilities has been at the heart of this decade’s progress in treating ovarian cancer, and the focus now is on combining PARP inhibitors with other types of therapies.

June 11th 2017, 6:03pm

FORCE Conference

There are several issues parents should consider before broaching the subject of genetic cancer risk with their children, explains Karen Hurley, a psychologist with the Cleveland Clinic.

June 11th 2017, 5:04pm

FORCE Conference

Finding out that you have a BRCA or other mutation that increases your risk of cancer is a frightening and often confusing prospect, but even one supportive voice can make a huge difference.

June 10th 2017, 9:04pm

FORCE Conference

Alan Blassberg, Director/Producer of Pink and Blue: Colors of Hereditary Cancer, discusses being a male BRCA carrier.

June 10th 2017, 8:09pm

FORCE Conference

Sharon Bober, PhD, discusses how patients can ask their doctors about sexual health.

June 10th 2017, 5:56pm

FORCE Conference

Those considering mastectomy to help prevent inherited breast cancer, or because they’ve been diagnosed with the disease, are likely to find themselves sorting through a host of complex questions.

June 10th 2017, 4:22pm

FORCE Conference

For women genetically predisposed to ovarian cancer, prevention is extremely important. But what are the most effective and least invasive prevention techniques, and when is the best time in life to employ them?

June 9th 2017, 11:58pm

FORCE Conference

Knowing that you have an inherited gene mutation can allow you and your family members to look into prevention or detect a cancer at an early stage.

June 9th 2017, 11:15pm

FORCE Conference

Angela Fishbaugh, author of "Angela's Decision," discusses how to discover your skills and story within.

June 9th 2017, 11:02pm

ASCO Annual Meeting

“This is the first phase 3 study to show an advantage of a PARP inhibitor over standard of care chemotherapy in breast cancer patients with a BRCA mutation,” said principal OLYMPIAD investigator Mark E. Robson, M.D., Clinic Director of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center.

June 9th 2017, 10:32pm

FORCE Conference

Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.

June 9th 2017, 8:48pm

FORCE Conference

Sue Friedman, executive director and founder of FORCE, is a hereditary breast cancer survivor herself and has been concentrating on being the support system for others that she didn’t have when she was going through her battle 20 years ago.

June 9th 2017, 8:03pm

FORCE Conference

The program XRAYS is a resource to help patients, survivors and their loved ones make sense of the articles on hereditary cancer they see in the mainstream media and via social media platforms.

June 9th 2017, 5:21pm

FORCE Conference

While genetic testing for cancer has some obvious benefits, it also creates ethical dilemmas in many cases.

June 8th 2017, 6:28pm

ASCO Annual Meeting

PolyBalm was effective in mitigating chemotherapy-related nail damage, according to a recent study presented at ASCO.